Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Breast cancer

breast-mm cancer-types/breast-cancer/overview
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
      • Diagnosis of ductal carcinoma in situ
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
      • Palliative care
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
      • Relationships
      • Practical issues
    • Support
    • Clinical trials
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
      • Diagnosis of ductal carcinoma in situ
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
      • Palliative care
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
      • Relationships
      • Practical issues
    • Support
    • Clinical trials
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
  1. Home
  2. Treatment
  3. Hormonal therapies
  4. Deciding about hormonal therapies
  • Treatment team
  • Deciding about treatment
  • Surgery
  • Radiotherapy
  • Chemotherapy
  • Hormonal therapies
    • Hormone receptors
    • Types of hormonal therapy
    • Side effects
    • Menopause and oestrogen production
    • Deciding about hormonal therapies
    • Questions to ask
  • Targeted therapies
  • Complementary & alternative therapies
  • Palliative care
  • Ductal carcinoma in situ
  • Lobular carcinoma in situ
  • Early breast cancer
  • Paget's disease of the nipple
  • Inflammatory breast cancer
  • Locally advanced breast cancer
  • Metastatic breast cancer
  • Follow-up
  • Advanced disease
  • Recurrent and secondary cancer
Loading...

Deciding about hormonal therapies

  • Printer-friendly version
  • A|A

When deciding about hormonal therapies it’s important to consider the likely benefits and possible side effects of the different treatments.

Hormonal therapies and early breast cancer

For women with early breast cancer, the long-term benefits and risks of taking tamoxifen are well known. Tamoxifen reduces the risk of breast cancer coming back and improves survival.

Studies have shown that treatment with an aromatase inhibitor reduces the risk of breast cancer coming back more than tamoxifen. However, studies have not been going long enough to say whether aromatase inhibitors improve survival more than tamoxifen. Also, we do not yet know the long-term side effects of aromatase inhibitors.

For post-menopausal women with a higher risk of breast cancer coming back, the short-term benefits of aromatase inhibitors outweigh the risks of side effects (both known and unknown).

For post-menopausal women with a lower risk of breast cancer coming back, it’s possible that long-term side effects of aromatase inhibitors (as yet unknown) outweigh the short-term benefits of treatment compared with tamoxifen.

CYP2D6 test for the effectiveness of tamoxifen

A number of consumers have raised questions about the effectiveness of CYP2D6 genotype testing for women considering tamoxifen as treatment for breast cancer.   

There have been a number of studies looking into the potential role of CYP2D6 genotype testing (a blood test) as a marker for whether an individual will be resistant to treatment with tamoxifen.

Currently, there is not enough evidence to recommend routine testing for the CYP2D6 genotype when making clinical decisions regarding the use of tamoxifen in either pre or post menopausal women.

Cancer Australia recommends consideration of the use of adjuvant hormonal therapy for most women with hormone receptor-positive early breast cancer. Women should make decisions about which hormonal therapy is most suitable for them in consultation with their medical oncologist.

As the biology of breast cancer is becoming better understood, the management of breast cancer is increasingly being tailored according to patient and tumour factors. Cancer Australia will continue to monitor new evidence and provide updated information as appropriate.

Hormonal therapies and metastatic breast cancer

For women who haven’t yet reached menopause and who have hormone receptor-positive breast cancer, treatment usually starts with tamoxifen with or without an ovarian suppression drug.

For women who have reached menopause and who have hormone receptor-positive breast cancer, treatment usually starts with an aromatase inhibitor. If a woman is already taking tamoxifen when her metastatic  breast cancer is diagnosed, it’s recommended that she changes to an aromatase inhibitor.

If a woman’s metastatic breast cancer stops responding to treatment with an aromatase inhibitor, or if she has side effects that are difficult to manage, she may be advised to change to a different type of hormonal therapy.

In general, fulvestrant and progestins are only recommended if other hormonal therapies have stopped controlling the cancer.

 

  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia